Teva’s $85 Million Opioid Settlement

July 31, 2019 by Rachel Minyard

Authored By: Ollie Lammers

According to Reuters, an Oklahoma judge recently approved an $85 million settlement with Teva Pharmaceutical Industries Ltd, resolving claims by the state attorney general that the company helped fuel the U.S. opioid epidemic.

The settlement resolved claims that Teva and other drug companies aided in causing the opioid epidemic. The case claimed the company was marketing opioids as safe and effective for everyday pain and downplaying the addictive qualities of the drug.

Teva’s settlement money will be deposited in a fund with the state and can only be used to address the opioid epidemic.

Teva did not admit any wrongdoing.

For more information, click here.

About Rachel Minyard

Rachel Minyard, Vice President of Marketing, joined Advocate Capital, Inc. in 2016. Ms. Minyard has a background in reporting, directing and producing media. Her goal is to help communicate Advocate Capital’s purpose to help plaintiff attorneys get even better results for their clients.

* In most jurisdictions, a law firm can recover finance charges related to funding case expenses from case awards, but the compliance requirements can be too expensive to implement. Only Advocate Capital, Inc. has the proprietary AdvoTrac^® expense tracking system and service team that allows firms to easily comply with allocation and reporting requirements. So, for example, if a firm recovers at least 90% of its advanced case expenses, like most of our clients, the annual net cost of funds is very small-typically less than 1%. Contact us to discuss how our program can work for your firm. All loans are subject to credit approval, and terms and conditions may vary.

Financial Services provided through Pinnacle Bank, which is a Member FDIC and Equal Housing Lender. Loans may be subject to credit approval.

About Rachel Minyard

Are You an Existing Client?